Rotigotine
- TRADE NAME: Neupro (Schwarz)
- INDICATIONS: Parkinsonism, restless legs syndrome
- CLASS: Dopamine receptor agonist
- HALF-LIFE: 5–7 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Antipsychotics, Levomepromazine, Memantine, Methyldopa, Metoclopramide, Risperidone, Zuclopenthixol
PREGNANCY CATEGORY: C
Neupro contains sodium metabisulfite which is capable of causing anaphylactoid reactions in patients with sulfite allergy.
Please login to see the rest of this drug profile
SKIN.
NAILS.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
OTIC.
RESPIRATORY.
OTHER.
Click on the DRUG REVIEW ARTICLE tab (above) to see a review of rotigotine in the Taylor & Francis journal Expert Opinion on Drug Safety. (Note that non-subscribers to the journal will only be able to see an abstract of the article.)
Page last updated 07/31/2023
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
